Key Insights

Highlights

Treatment Research

2 treatments under study, led by Blood Sampling For Dosage

Research Leaders

12 sponsors active, led by University Hospital, Lille

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Recruiting2

Clinical Trials (2)

Showing 2 of 2 trials
NCT06869499Not ApplicableRecruiting

Study of the Prevalence of Acid Sphingomyelinase Deficiency/Niemann Pick AB and B Disease in Patients With Diffuse Interstitial Lung Disease

NCT04234724Not ApplicableRecruitingPrimary

Physiological Effects of ANGPTL3 Variants in Humans

Showing all 2 trials

Research Network

Common Treatments

  • Blood Sampling For Dosage1
  • Kinetics Test Oral Fat Tolerance Test And An Oral Glucose Tolerance Test1

Active Sponsors

  • University Hospital, Lille1
  • University of Pennsylvania1
  • Tenon Hospital, Paris1
  • Hospices Civils de Lyon1
  • Wladimir MAUHIN, Dr1

Top Investigators

Related Conditions

  • Thrombopenia1
  • Splenectomy1
  • Splenomegaly1
  • Interstitial Lung Disease Ild1

Activity Timeline